Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Industry Insights Seminar Series

The Industry Insights Seminar Series is hosted by the Business Partnerships Office

  • 12.00 -1.00 pm
  • In person and online
  • In person at Institute of Developmental & Regenerative Medicine (IDRM), Old Road Campus, Headington, OX3 7TY
  • Networking & 1:1 meeting opportunities

The Industry Insight Seminars provide the opportunity for Oxford scientists to attend a scientific seminar of interest and to network with industry scientists. Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics.  Speakers are encouraged to bring along colleagues to facilitate networking; one to one meetings can be facilitated upon request.  Seminars are suitable for all scientists with some knowledge or interest in each topic area, from PhD students to PIs.  Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend. 

Please contact Sheena Lee if you have any questions or have an industry partner you would like to invite to speak

10th June 2026: Precision Medicine in Clinical Trials: AI Imaging for Lung Disease

Presenter: Professor Muhunthan Thillai, CEO Qureight and Consultant Physician at Royal Papworth Hospital Cambridge

Company: Qureight

Description: Qureight is a tech-first, AI-powered imaging CRO. They deliver a suite of products through a proprietary data and imaging curation platform. This enables the analysis of clinical imaging and other healthcare data from patients with lung and heart disease, helping customers bring treatments to market, faster. They provide automated image management and AI analysis in therapeutic areas such as Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Hypertension and Bronchiectasis.

The presentation will be followed by a panel discussion: 

  • Use of imaging technology to speed up clinical trials
  • The regulatory pathway for AI imaging in clinical trials
  • Digital Twins and Synthetic Placebo Arms

Led by: 

  • Muhunthan Thillai, CEO Qureight and Consultant Physician at Royal Papworth Hospital Cambridge
  • Simon Walsh, CSO Qureight and Consultant Radiologist at Imperial College London
  • Rebecca Simmons, COO Qureight
  • Steven Bishop, CMO Qureight
  • Jessica Payne, CCO Qureight

 

 

 

 

 

Register for the June seminar

 

On this page

In this section